Susquehanna International Group’s Orphazyme A/S ORPH Stock Holding History

Susquehanna International Group’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,900	Closed	-$50K	–	14509
2021 Q4	$50K	Sell	20,900 -20,100	-49%	-$71K	﹤0.01%	12552
2021 Q3	$169K	Sell	41,000 -328,300	-89%	-$1.69M	﹤0.01%	11681
2021 Q2	$2.71M	Buy	+369,300	New	+$2.98M	﹤0.01%	5253

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's ORPH Position: Q1 2022 in Review

Susquehanna International Group sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 114,372 shares — an estimated $276K sold.

Susquehanna International Group first reported a position in ORPH in Q2 2021 and held it in 3 quarters. The position peaked at $1.13M in Q2 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Susquehanna International Group reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Susquehanna International Group sold 114,372 Orphazyme A/S shares in Q1 2022, an estimated $276K.
Susquehanna International Group first reported a position in Orphazyme A/S in Q2 2021 and held it in 3 quarters.
Susquehanna International Group's Orphazyme A/S position peaked at $1.13M in Q2 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.